26 May 2022
GFI sees growth in Australian medical cannabis prescriptions
Greenfern Industries’ GMP medicine prescription sales in the Australian market are going from strength to strength. Read more ...
Read More
19 May 2022
First products will deliver wider treatment options
Successful assessment by the Medicinal Cannabis Agency of Cannasouth’s first medicinal cannabis products will deliver wider treatment options to New Zealand ...
Read More
16 May 2022
Delivery mode: Helius Therapeutics names new CCO
Julie Curphey has been appointed Chief Commercial Officer (CCO) at Helius Therapeutics – New Zealand’s largest licenced medicinal cannabis company. Prior ...
Read More